Most recently, Transition Bio raised $13.3M in its Early Stage VC (Oct 2024).
- ·Watch Transition Bio: the Monday email on marks, rounds and moves
Transition Bio round by round
3 roundsHow much has Transition Bio raised?
Transition Bio has raised $76.5 million across 3 recorded rounds since 2022. The largest was a $6 million early-stage round in Dec 2023; the most recent was a $13.3 million early-stage round in Oct 2024.
Transition Bio has filed 4 Form Ds with the SEC since 2022, most recently in Oct 2024 ($13.3 million sold to 8 investors).
Transition Bio investors
6 investors are on record for Transition Bio, including Bristol-Myers Squibb, Lifeforce Capital, Magnetic Ventures and Northpond Ventures. The early-stage round in Oct 2024 drew 8 investors.
6 investors have backed Transition Bio.
Frequently asked about Transition Bio
- How much has Transition Bio raised?
- Transition Bio has raised $76.5M in total across 3 recorded funding rounds.
- When was Transition Bio's last funding round?
- Transition Bio's most recent recorded round was Early Stage VC in Oct 2024, raising $13.3M.